Uniphore Acquiring ActionIQ and Infoworks to Deliver the Industry’s First Zero Data AI Cloud
5.12.2024 11:57:00 CET | Business Wire | Press release
Strategic acquisitions unleash Enterprise data to create knowledge, fine tune AI models, create powerful AI agents and drive business transformation.
Uniphore, the global leader in Enterprise AI, today announced it is acquiring two industry-leading data powerhouses, ActionIQ and Infoworks, which significantly expands its AI-powered offerings. These strategic acquisitions extend Uniphore’s comprehensive end-to-end Enterprise AI platform and will deliver the industry’s first Zero Data AI Cloud.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205133623/en/

Uniphore is acquiring two industry-leading data powerhouses, ActionIQ and Infoworks, which significantly expands its AI-powered offerings. These strategic acquisitions extend Uniphore’s comprehensive end-to-end Enterprise AI platform and will deliver the industry’s first Zero Data AI Cloud. (Graphic: Business Wire)
A Zero Data AI Cloud enables enterprises to overcome the largest barriers of AI adoption – data access, accuracy, flexibility and data sovereignty. It removes data bottlenecks and delivers powerful AI capabilities while preserving customers’ existing data landscape and avoids complex integration challenges. Uniphore’s Zero Data AI Cloud is built on an infrastructure-agnostic architecture that creates a seamless data fabric across any data platform, enterprise application, or cloud environment.
By bringing Uniphore, ActionIQ and Infoworks together, enterprise customers will have access to an entire suite of AI capabilities that empowers organizations to move beyond proof-of-concept AI trials into full scale implementation, accelerating their digital transformation.
In addition to their industry-leading customer data solutions, ActionIQ brings their Composable Zero-copy Data Platform, which enables enterprises to connect all data, from anywhere, and make it AI-ready without requiring any long integration or ETL projects. Infoworks brings their Enterprise Data Platform which includes intelligent AI data agents that can discover, identify, organize, catalogue and clean enterprise data with little human supervision.
Their combined expertise and innovative technology enable enterprises to leverage all their data for AI initiatives without the need to move, transform, or copy it, and will accelerate the time to achieve results down to weeks, not years, all while maintaining high standards of governance and security.
“This is a defining moment for Enterprise AI,” said Umesh Sachdev, CEO and co-founder of Uniphore. “With the acquisitions of ActionIQ and Infoworks, Uniphore is enabling a Zero Data AI Cloud for the world’s largest companies, equipping them with the tools to fast-track AI deployments and drive measurable business outcomes.”
Tasso Argyros, CEO and co-founder of ActionIQ said, "At ActionIQ we’ve been hyper-focused on data and helped create and now lead the massive category of Customer Data Platforms, helping dozens of F1000 enterprises transform their Customer Experience. It is my belief that the future of CDPs is AI and CX Agents. Bringing together Uniphore's industry-leading AI capabilities and ActionIQ's data and CX capabilities will allow us to continue leading the market and deliver world class solutions to the world.”
"Data has long been a challenge for enterprises to modernize their operations and embracing AI innovations," said Amar Arsikere, Founder at Infoworks. "At Infoworks, we are redefining data engineering with groundbreaking automation that seamlessly handles every data task for any kind of data. By joining forces with Uniphore, we now deliver a comprehensive Data + AI solution that accelerates the development of Enterprise AI applications and empowers organizations to unlock their full potential."
Powering Business Transformation with a Zero Data AI Cloud
Uniphore is pioneering a revolutionary approach leveraging a multi-layered AI architecture comprised of a composable data layer, knowledge layer, model layer and agentic layer. Within each layer, Uniphore has feature-rich solutions, with continued investments planned in each area.
- Composable Data Layer
Organizations can instantly harness their enterprise data without complex migrations or copies. Enterprises can maintain complete control of their data assets across global operations. It reduces AI deployment time from months to weeks.
- Knowledge Layer
Enterprise data is transformed into an AI-ready knowledge lake. It ensures that AI outputs are grounded in an organization’s business reality without hallucinations. This allows organizations to fully leverage and protect their institutional knowledge and experience.
- Model Layer
All the capabilities in this layer enable countless options for enterprises to easily pick relevant foundational models and/or work with multiple models to meet their business needs. Within the model layer there are also tooling capabilities to easily create fine-tuned industry and enterprise specific small language models.
- Agentic Layer
This is where digital transformation is accelerated with ready-to-deploy AI agents across core functions such as customer service, marketing, HR, sales, and more. Further, this layer empowers the functional user and citizen developer to build and manage intelligent and personalized AI agents for specific business needs and workflow automation.
With this unique 4-layer approach, customers now can fully leverage Uniphore’s suite of end-to-end AI capabilities through an open architecture, while ensuring data sovereignty and enterprise-grade scalability. Organizations maintain complete control while deploying AI solutions across any scale—from department level solutions all the way to sophisticated global operations.
Enterprise AI That Delivers Results
Large enterprises are increasingly looking for solutions that enable them to become more agile, responsive, and data-driven in their decision-making. With the acquisition of ActionIQ and Infoworks, Uniphore is the only Enterprise AI company with an end-to-end solution for a Zero Data AI Cloud that delivers:
- Accelerated Time to Value
Now, customers can deploy enterprise-wide AI solutions in weeks, by enabling seamless data access. With support for multi-cloud and virtual private cloud deployments, enterprises’ needs for flexible and secure access to data are achieved. Further, Uniphore delivers enterprises an end-to-end AI stack with pre-built applications today for customer service, sales, HR, marketing, and more as well as the capabilities to build their own intelligent agents.
- Superior AI Performance
High accuracy is now attainable because of fine-tuned industry and enterprise models that access an enterprise’s knowledge in any data format. The Uniphore solution also delivers consistent results aligned with any company’s business context beyond what traditional RAG solutions provide. Because of Uniphore’s open architecture and orchestration capabilities, enterprises can leverage their existing best-in-class solutions, based on business needs, to support multiple models.
- Enterprise Data Freedom
The Uniphore Zero Data AI Cloud enables the use of multi-modal data across any platform, architecture, or application. There no longer needs to be any disruption to existing systems and workflows and no vendor lock-in. This gives customers complete control over sensitive enterprise knowledge and information.
This strategic move from Uniphore cements its leadership position as an Enterprise AI innovator. Uniphore will continue to deliver industry-leading solutions, including expanding the ActionIQ composable CDP solution to capitalize on the multi-billion-dollar CDP market opportunity and will continue to enhance its established portfolio of solutions that currently are in use at some of the world’s largest corporations. The ActionIQ solution is currently listed as a leader in the Forrester Wave competitive report on Customer Data Platforms.
For additional information on these acquisitions, please see our information page, which has a fact sheet on ActionIQ and afact sheet on Infoworks. Tidal Partners LLC acted as exclusive financial advisor to Uniphore on the transaction.
About Uniphore
Uniphore is a leading B2B AI-native company with decades of proven success. Engineered for scalability and tailored for enterprise needs, we drive AI transformation that delivers real business impact across multiple industries and the largest global deployments. Our Zero Data AI Cloud is built on a multimodal AI and data platform and is at the heart of this transformation, enabling businesses to swiftly deploy AI across the enterprise. With our Zero-Data AI Cloud, organizations can harness their data and create scalable, domain-specific AI models to democratize enterprise knowledge—all while ensuring security, sovereignty, and rapid value delivery. Today, Uniphore’s technology empowers over 750,000 end-users across 1,600 enterprises in 20 countries. Discover the unmatched capabilities of Uniphore—because there’s no AI like it™.
For more information about Uniphore’s solutions, visit [www.uniphore.com]
View source version on businesswire.com: https://www.businesswire.com/news/home/20241205133623/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom